Analyst Price Target is $8.80
▲ +426.95% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for NextCure in the last 3 months. The average price target is $8.80, with a high forecast of $16.00 and a low forecast of $1.00. The average price target represents a 426.95% upside from the last price of $1.67.
Current Consensus is
Buy
The current consensus among 4 polled investment analysts is to buy stock in NextCure. This rating has held steady since August 2021, when it changed from a Hold consensus rating.